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Open spina bifida or myelomeningocele (SBM) is the 
most common birth defect involving the central nervous 
system, second only in incidence to congenital cardiac 
disease. Although recognised since antiquity, with 
anthropological relics depicting affected individuals and 
suggestive descriptions in the writings of Hippocrates and Galen, the 
first definitive description was by the Dutch clinician Peter van Forest 
in 1610. His compatriot, Nicholas Tulp, famous for Rembrandt’s ‘The 
anatomy lesson of Dr Tulp’, introduced the term spina bifida 31 years 
later, along with the first clear illustration of the condition.[1]  
Despite various attempts at treatment, outcome remained very 
poor until the mid-20th century. The development of modern 
neurosurgery (closure of the lesion and treatment of hydrocephalus) 
and the advent of treatment for the neuropathic bladder addressed 
the major causes of mortality. More recently, advances in antenatal 
diagnosis and perhaps, most important of all, successful prevention 
strategies through the use of preconception folic acid, led to a fall in 
the number of new cases.
SBM is, however, still common throughout much of the developing 
world, and many patients remain poorly treated. There are few 
conditions where initial management (or mismanagement) has 
such a profound impact on survival and long-term quality of life. 
Appreciation of the value of various specialties working together led 
to the establishment of multidisciplinary spina bifida clinics. One such 
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Myelomeningocele is the most complex congenital abnormality compatible with long-term survival. − David McLone
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clinic was established at Red Cross War Memorial Children’s Hospital 
in 1967 (J C de Villiers − personal communication). This review, and 
the accompanying articles written by members of this clinic, aims to 
highlight the key challenges in management, demonstrate the value 
of multidisciplinary care, and emphasise the need to offer better 
treatment in South Africa (SA) in order that these children and adults 
can achieve their true potential.
Terminology
The term spina bifida is used to refer to a range of different conditions. 
The simplest form is incomplete closure of the posterior elements of one 
of the lower lumbar or sacral vertebrae. This is very common (around 
10% of the population) and incidentally noted on X-ray, but seldom of 
any clinical relevance. Spina bifida occulta or closed spina bifida refers 
to a range of rare but characteristic congenital abnormalities involving 
the lower spinal cord, such as a lipoma, myelocystocele or split 
cord; usually there is an overlying cutaneous abnormality (such as a 
subcutaneous lipoma, naevus or hairy patch) and pathophysiologically 
the spinal cord is tethered and vulnerable. Spina bifida aperta or open 
spina bifida is almost always a myelomeningocele, where the spinal 
cord and meninges are exposed on the dorsal surface of the infant at 
birth (Fig. 1). This is invariably accompanied by a range of other central 
nervous system abnormalities (Fig. 2).
Spina bifida is part of a spectrum of conditions referred to by the 
term dysraphism, which encompasses a range of conditions (Table 1) 
that result from an embryological error, usually abnormal closure of 
the neural tube.
Embryology and prevention
Virtually the entire central nervous system develops from ectoderm, with 
the neuro-ectoderm thickening into a neural plate which then folds over 
to close in the midline through the process of primary neurulation. [2] 
This process occurs extremely early in embryonic life (completed by 
day 28) and errors lead to neural tube defects (NTDs). Presenting as 
either anencephaly at the rostral (brain) end or myelomeningocele at the 
caudal (spinal) end, the incidence of NTDs ranges from 0.77 to 6.1/1 000 
live births in SA, with higher incidences reported in rural areas.[3] The 
lower sacral segments form through the more complex process of caudal 
regression or secondary neurulation and errors result in various forms of 
spina bifida occulta, such as caudal lipoma.
Enlarged ventricles
Cerebellar vermis
Syrinx
Myelomeningocele
Open spinal cord
Bone (vertebrae)
Fig. 2. Diagram showing sagittal impression of the myelomeningocele and 
Chiari II malformation.
Fig. 1. Clinical photograph showing a typical myelomeningocele. The open 
spinal cord is readily appreciated, with the midline fold continuous rostrally 
with the central canal of the spinal cord. Leaking CSF can also be seen.
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One of the most effective primary prevention 
strategies ever described is the prevention of 
NTDs by administration of folic acid prior 
to conception, a strategy that is supported 
by evidence from a number of prospective 
randomised trials in various countries. [4] 
One of the public health strategies this 
has led to is food fortification, which was 
successfully implemented in SA.[5] The 
mechanism by which folate supplementation 
reduces the incidence of NTDs is unknown 
− genetic factors clearly play an important 
role and the aetiology can truly be described 
as multifactorial.
Antenatal diagnosis
Although maternal serum alpha-fetoprotein 
remains a useful screening investigation, 
the focus has shifted to prenatal ultrasound 
screening, which should detect more than 90% 
of cases.[6] Performing an anatomical scan at 
18 - 23 weeks requires appropriate training 
as a level 3 scanner, since the consequences 
of missing the diagnosis can be very costly, 
as evidenced by the magnitude of ‘wrongful 
birth’ medicolegal claims. An antenatal 
diagnosis of SBM should be followed by non-
directive counselling, allowing the family to 
choose between terminating or continuing 
the pregnancy. Although a prospective trial 
showed some benefit following intrauterine 
closure of SBM,[7] there is still some scepticism 
about the true benefit of this intervention 
which is not yet available in SA. Anyone 
wishing to consider this option is encouraged 
to contact a paediatric neurosurgeon for advice 
at the earliest possible opportunity. At this 
stage, the greatest priority in our country is to 
optimise primary prevention and ensure early 
prenatal diagnosis.
Perinatal management
For those parents who elect to continue with 
the pregnancy, decisions around mode of 
delivery should be based on obstetric criteria, 
although for most SBM babies born in SA the 
diagnosis is not made antenatally. Either way, 
it is obvious upon inspection of the newborn 
infant’s back. The key imperatives are: 
• initial resuscitation, taking particular care
over the airway because of the potential
for brainstem dysfunction
• appreciation of the fact that the lesion on
the back represents the open and exposed
spinal cord, which must be kept clean
and sterile, ideally protected by a saline-
soaked gauze dressing
• evaluation of the anatomical level of
the lesion and correlating this with the
neurological level (motor function in
lower limbs).
The definitive treatment is surgical closure 
before the lesion is colonised, ideally within 
24 hours but definitely within 72 hours. The 
goal of surgery is to close the dura mater 
and skin over the spinal cord to prevent 
central nervous system infection, but this 
does not reverse the congenital neurological 
deficit. Although a neurosurgeon should 
be the practitioner best trained to perform 
this surgery, many of these children are still 
managed by other surgical specialists in SA 
and other developing countries. 
Some authors recommend administration 
of intravenous antibiotics if the lesion is 
leaking cerebrospinal fluid (CSF), as the latter 
may increase the risk of ventriculitis.[8] The 
use of antibiotics must not engender a false 
sense of security, and closure should still 
be performed as soon as possible as this is 
the most effective antimicrobial strategy. In 
developing countries, many of these children 
present too late for primary closure and if the 
back is kept clean, the lesion may epitheliase 
over a period of weeks. Surgery is usually still 
indicated in patients who present late, as the 
mass tends to enlarge with time.
Postoperatively, the infant is nursed flat 
for 5 days to reduce pressure on the wound 
to avoid a CSF leak, oral feeds (ideally 
breastfeeding) are commenced, watching for 
evidence of bulbar dysfunction, and the head 
circumference is measured daily to monitor 
for hydrocephalus. The parents should be 
counselled by a social worker with regard 
to the imperative for folate prophylaxis and 
assisted in applying for a Care Dependency 
grant. A high incidence of latex allergy has 
been reported in SBM patients, but this was 
not borne out in a study in Cape Town, 
perhaps owing to a longstanding policy of 
avoiding the use of latex products in these 
patients from the outset.[9]
Other neurosurgical 
issues
Although only a minority of children born 
with SBM have hydrocephalus that is apparent 
at birth, most will go on to develop progressive 
hydrocephalus that requires treatment. This 
may entail insertion of a ventriculoperitoneal 
shunt, or in some centres, endoscopic surgery 
− third ventriculostomy,[10] possibly with 
choroid plexus coagulation to reduce CSF 
production.[11] 
With SBM, what one sees on the back 
is the tip of the iceberg as these patients 
invariably have a Chiari II malformation 
(often incorrectly referred to as the Arnold-
Chiari malformation), typical features of 
which are cerebellar herniation through the 
foramen magnum and brainstem distortion 
(Fig. 2). This is, however, a pancerebral 
malformation as the entire central nervous 
Table 1. Classification of dysraphism
Cranial
Open Anencephaly (and occasional encephaloceles)
Closed Encephalocele; cranial dermal sinus
Spinal
Open Spina bifida aperta: myelomeningocele/meningomyelocele
Closed Spina bifida occulta
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system is involved.[12] The onset of bulbar symptoms often led to 
posterior decompression surgery in times past, but recognition that 
early brainstem dysfunction is not due to cerebellar herniation alone 
has led to a substantial decrease in this procedure.[13] 
There are various possible causes for neurological deterioration 
in someone with a history of myelomeningocele, including 
shunt malfunction (first and foremost), Chiari II malformation, 
syringomyelia, progressive scoliosis and secondary tethering of the 
spinal cord. The last may present with neurological deterioration 
(such as new bladder symptoms or worsening gait) or back pain.
Urological 
Bladder dysfunction is always present in SBM, resulting in a clinical 
picture referred to as the neurogenic or neuropathic bladder. This 
results in urinary incontinence as well as progressive renal damage 
due to recurrent urinary tract infections and dynamic factors such as 
high bladder storage pressures and secondary vesico-ureteric reflux. 
These complications can often be detected at primary care level 
by regular clinical assessment coupled with urinalysis and culture, 
serum chemistry and simple radiological studies where appropriate. 
More complex investigations such as invasive urodynamic studies 
are essential in evaluating function and planning management, but 
regrettably these are rarely available in SA.
The primary goals of management are to normalise bladder 
pressure and achieve social continence. The cornerstone 
of management is clean intermittent catheterisation, which in 
our experience can be successfully used even under adverse 
socio-economic circumstances. This is often supplemented by 
anticholinergic drugs (either oral or intravesical) and surgery when 
conservative management fails.[14]
Developmental 
Although the focus readily falls on the obvious spinal abnormality 
and its direct consequences, it is important to remember that 
SBM is invariably accompanied by the Chiari II malformation, 
a pancerebral malformation, as discussed above. To this may be 
added the effects of hydrocephalus and its management, epilepsy, 
endocrine dysfunction, repeated hospitalisations and other medical 
complications. Despite this, the majority of SBM patients have an 
intelligence quotient (IQ) in the average to low average range,[15] but 
in some IQ is in the high range.
SBM is a complex neurodevelopmental disorder with a well-
characterised cognitive pattern.[16] The value of early awareness of the 
strengths and weaknesses of the individual child is obvious. While an 
inclusive education policy is in place in SA, few mainstream schools 
in the public sector are able to fully meet the needs of these children, 
which include learning support, physical exercise such as sport, and 
accessible classrooms, toilets and other facilities.
Orthopaedic
Orthopaedic surgeons have much to offer these patients, either in 
correcting spinal deformity or optimising mobility. Spinal deformity 
tends to occur only in paraplegic patients and needs surgical 
correction if progressive. The neurological level, which is defined 
as the lowest motor segment with at least MRC grade 3/5 power, is 
the most important factor in determining walking potential and also 
determines the pattern of lower limb deformities.[17]
Virtually all SBM patients require treatment of foot deformities 
with the goal of obtaining a plantigrade, mobile and braceable foot 
and avoiding trophic ulceration.[18] Deformities, including equinus, 
club foot, valgus and cavovarus, can be corrected by a range of 
operations. Trophic ulcers are due to a stiff plantigrade foot or 
a neglected injury in an insensate foot; treatment often requires 
rotating a flap to reconstitute normal skin and fat pad as well as 
removing the bony prominence under the ulcer. If inadequately 
treated, trophic ulcers lead to significant morbidity and can result 
in amputation. Other complications to look for include Charcot 
arthropathy and fractures that can present with swelling, warmth and 
oedema, mimicking cellulitis or septic arthritis.
Long-term quality of life
With early closure and effective treatment of common complications 
such as hydrocephalus and neuropathic bladder, the majority of these 
patients survive into adulthood − a marked contrast to the situation 
50 years ago when survival was around 10%. Most modern series 
report survival into adulthood of well over 50%,[19] although there 
remains a troubling risk of death in adults.[21] 
The focus now shifts to transition of care through adolescence and 
addressing the issues that impair quality of life, in addition to all the 
medical domains listed above. The neuropathic bladder is usually 
accompanied either by faecal incontinence or chronic constipation, 
which may necessitate daily bowel washouts. A relatively neglected 
area is that of sexuality and parenthood among adults with SBM.[21] 
Although IQ scores suggest a good prognosis, this tends to over-
estimate the capacity for social integration.[22]
Various support groups and other organisations have evolved over 
the years, many of which work through the International Federation 
for Spina Bifida and Hydrocephalus (IFSBH).
Closed spinal dysraphism
Although folate prophylaxis and antenatal diagnosis have led to a fall 
in the number of children born with SBM, this has not affected the 
number of children born with closed dysraphism who have many 
of the same urological and orthopaedic challenges, but do not have 
hydrocephalus, Chiari II malformation or the cognitive issues typical 
of SBM. Although a magnetic resonance imaging (MRI) scan is 
usually required to make the diagnosis, it is usually apparent to the 
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astute clinician given the almost invariable occurrence of an overlying 
cutaneous lesion. Missing the diagnosis may result in progressive 
neurological deterioration, which seldom improves following surgery. 
Conclusion
SBM is a complex disorder that requires input from many different 
health professionals. The rewards for managing these children well 
are substantial as they can lead full and productive lives. Although 
there is no doubt about the value of a multidisciplinary clinic, the 
family practitioner, who co-ordinates care, is essential. With the 
resources available in SA, there is little doubt that these children 
deserve better care than they often receive.
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